By Bart Schaneman

Valuating a cannabis business requires coming up with creative comparisons to established industries, such as tulips and wine.

That’s the space Justin Costello operates in. The CEO of Seattle-based GRN Funds, he brings years of experience making deals in the investment banking sector and said he has completed 80-plus cannabis deals.

By John Schroyer

Two local ballot measures to grow Detroit’s once-sizable medical marijuana industry have overcome significant legal hurdles and will now go before voters in November.

The proposed changes, if approved by voters, would likely result in a broadening of the MJ-related business opportunities in Michigan’s biggest city.

By Kristen Nichols

The nascent CBD market is hot: The cannabis compound is popping up in a dizzying variety of products, from maple candies to skin creams to dog treats.

But a market researcher who produced some of the most exhaustive investigations yet into CBD’s market potential has some cold water to throw on CBD’s fire.

By Bart Schaneman, John Schroyer and Omar Sacirbey

A new legal interpretation says marijuana consumption lounges don’t violate Nevada law, U.S. senators are calling for national cannabis testing protocols, and Maine releases draft rules for its recreational MJ industry.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

By Matt Lamers

New Brunswick's groundbreaking deal to buy a combined 100 million Canadian dollars ($82 million) worth of cannabis per year from two licensed producers could be a harbinger of things to come for provinces aiming to lock up supply before next year's launch of adult-use cannabis.

By Matt Lamers

Canada’s cannabis industry is pushing back against the Ontario government’s blueprint for regulating marijuana, urging the province to reconsider its plan to handle recreational cannabis sales while shutting the private sector out of the retail rec business.